Abstract
Embryonic rat bones labeled with4 5CaCl2are stimulated in vitro by parathyroid extract to release45Ca. Mithramycin prevents this active release over a broad range of dose levels that are nonlethal to the bones, as evidenced by their subsequent responsiveness to additional parathyroid extract. The similarity of dose levels used to concentrations (based on calculated dilution) after clinical administration supports the interpretation that clinical effects of mithramycin in hypercalcemic patients are due to a direct effect on bone.
Original language | English |
---|---|
Pages (from-to) | 74-76 |
Number of pages | 3 |
Journal | Cancer Research |
Volume | 32 |
Issue number | 1 |
State | Published - Jan 1972 |
Externally published | Yes |